Research programme: liposomal vaccines - Xenetic Biosciences
Alternative Names: Hepatitis B vaccine - Xenetic Biosciences; HepaXen; LipoNeu; LipoRab; LipoTet; Pneumococal vaccine - Xenetic BiosciencesLatest Information Update: 27 Nov 2014
At a glance
- Originator Lipoxen Technologies
- Developer Xenetic Biosciences
- Class Bacterial vaccines; DNA vaccines; Hepatitis B vaccines; Pneumococcal vaccines; Protein vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B; Pneumococcal infections
- Discontinued Hepatitis E; Rabies; Tetanus
Most Recent Events
- 27 Nov 2014 No development reported - Preclinical for Hepatitis B (Prevention) in USA (Parenteral)
- 27 Nov 2014 No development reported - Preclinical for Pneumococcal infections (Prevention) in India (Parenteral)
- 27 Nov 2014 No development reported - Preclinical for Pneumococcal infections (Prevention) in USA (Parenteral)